Education
About Us
Working with TipRanks
Follow Us
Sanara MedTech (SMTI)
NASDAQ:SMTI
Total Valuation
Sanara MedTech has a market cap or net worth of $273.57M. The enterprise value is $304.00M.
Market Cap$273.57M
Enterprise Value$304.00M
Share Statistics
Sanara MedTech has 8,887,853 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,887,853
Owned by Insiders51.62%
Owned by Institutions0.25%
Financial Efficiency
Sanara MedTech’s return on equity (ROE) is -0.25 and return on invested capital (ROIC) is -9.37%.
Return on Equity (ROE)-0.25
Return on Assets (ROA)-0.11
Return on Invested Capital (ROIC)-9.37%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee614.70K
Profits Per Employee-70.30K
Employee Count141
Asset Turnover0.98
Inventory Turnover2.96
Valuation Ratios
The current PE Ratio of Sanara MedTech is -29.15. Sanara MedTech’s PEG ratio is 1.35.
PE Ratio-29.15
PS Ratio0.00
PB Ratio7.36
Price to Fair Value7.15
Price to FCF-120.97
Price to Operating Cash Flow-630.30
PEG Ratio1.35
Income Statement
In the last 12 months, Sanara MedTech had revenue of 86.67M and earned -9.66M in profits. Earnings per share was -1.14.
Revenue86.67M
Gross Profit78.53M
Operating Income-6.72M
Pretax Income-9.66M
Net Income-9.66M
EBITDA-1.86M
Earnings Per Share (EPS)-1.14
Cash Flow
In the last 12 months, operating cash flow was -428.30K and capital expenditures -1.89M, giving a free cash flow of -2.31M billion.
Operating Cash Flow-428.30K
Free Cash Flow-2.31M
Free Cash Flow per Share-0.26
Dividends & Yields
Sanara MedTech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.04
52-Week Price Change0.82%
50-Day Moving Average31.14
200-Day Moving Average33.05
Relative Strength Index (RSI)46.21
Average Volume (3m)23.95K
Important Dates
Sanara MedTech upcoming earnings date is Aug 18, 2025, TBA Not Confirmed.
Last Earnings DateMay 14, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend Date―
Financial Position
Sanara MedTech as a current ratio of 2.18, with Debt / Equity ratio of 121.95%
Current Ratio2.18
Quick Ratio2.00
Debt to Market Cap0.11
Net Debt to EBITDA-8.82
Interest Coverage Ratio-2.15
Taxes
In the past 12 months, Sanara MedTech has paid 247.35K in taxes.
Income Tax247.35K
Effective Tax Rate-0.03
Enterprise Valuation
Sanara MedTech EV to EBITDA ratio is -160.24, with an EV/FCF ratio of -1.30K.
EV to Sales3.44
EV to EBITDA-160.24
EV to Free Cash Flow-1.30K
EV to Operating Cash Flow-12.53K
Balance Sheet
Sanara MedTech has $20.69M in cash and marketable securities with $44.72M in debt, giving a net cash position of $24.03M billion.
Cash & Marketable Securities$20.69M
Total Debt$44.72M
Net Cash$24.03M
Net Cash Per Share$2.70
Tangible Book Value Per Share-$0.67
Margins
Gross margin is 89.41%, with operating margin of -7.75%, and net profit margin of -11.15%.
Gross Margin89.41%
Operating Margin-7.75%
Pretax Margin-11.15%
Net Profit Margin-11.15%
EBITDA Margin-2.15%
EBIT Margin-7.83%
Analyst Forecast
The average price target for Sanara MedTech is $49.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$49.00
Price Target Upside59.19% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast34.65%
EPS Growth Forecast-128.56%